TWI482964B - Method and device for measuring hematocrit (hct) - Google Patents

Method and device for measuring hematocrit (hct) Download PDF

Info

Publication number
TWI482964B
TWI482964B TW101144249A TW101144249A TWI482964B TW I482964 B TWI482964 B TW I482964B TW 101144249 A TW101144249 A TW 101144249A TW 101144249 A TW101144249 A TW 101144249A TW I482964 B TWI482964 B TW I482964B
Authority
TW
Taiwan
Prior art keywords
detecting
blood
pair
hematocrit
response current
Prior art date
Application number
TW101144249A
Other languages
Chinese (zh)
Other versions
TW201421022A (en
Inventor
Yao Chun Lai
Yi Lung Chen
Chien Hung Lai
Po Hao Lin
Ya Sian Lin
Shih Jen Lu
Chih Wei Liu
Original Assignee
Broadmaster Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Broadmaster Biotech Corp filed Critical Broadmaster Biotech Corp
Priority to TW101144249A priority Critical patent/TWI482964B/en
Publication of TW201421022A publication Critical patent/TW201421022A/en
Application granted granted Critical
Publication of TWI482964B publication Critical patent/TWI482964B/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Description

血比容檢測方法及其檢測系統Hematocrit detection method and detection system thereof

本發明關於一種檢測方法及其系統,特別是指一種檢測血液中血比容(Hematocrit,Hct)的方法及應用該檢測方法的檢測系統。The invention relates to a detection method and a system thereof, in particular to a method for detecting hematocrit (Hct) in blood and a detection system using the same.

血比容(Hematocrit,Hct),又稱為血液容積百分比,係指在一定量的血液中所含的紅血球數量比例,常作為診斷貧血或心血管疾病的指標之一。然而,對於血糖值的量測,血比容往往也是影響血糖量測值的關鍵因素之一,因此為了精確的量測血糖值,常需要先量測出受測者的血比容,再根據血比容進行血糖量測值的校正。Hematocrit (Hct), also known as the percentage of blood volume, refers to the proportion of red blood cells contained in a certain amount of blood, and is often used as an indicator for diagnosing anemia or cardiovascular disease. However, for the measurement of blood glucose level, hematocrit is often one of the key factors affecting the blood glucose measurement. Therefore, in order to accurately measure the blood glucose level, it is often necessary to measure the blood specific volume of the subject first, and then according to The hematocrit is corrected for blood glucose measurements.

傳統的血比容量測大多採用人工或是特殊機器(例如血球計數機),前者存在著操作複雜與耗時的缺點,而後者則需要較高採購與維護的成本缺點。Traditional blood specific capacity tests mostly use manual or special machines (such as blood cell counting machines). The former has the disadvantages of complicated operation and time consuming, while the latter requires high cost disadvantages of procurement and maintenance.

因此,是否有一種方法或是機制,可以提高血比容量測值的精準度與可靠性,且具有簡易的操作方式供受測者進行量測作業。Therefore, is there a method or mechanism that can improve the accuracy and reliability of blood specific volume measurement, and has a simple operation mode for the subject to perform measurement operations.

根據本發明之一範疇,在於提供一種檢測血液中血比容(Hematocrit(Hct))的方法及應用該檢測方法的檢測裝置。According to one aspect of the present invention, there is provided a method for detecting hematocrit (Hct) in blood and a detecting device using the same.

根據本發明之一實施例,血比容檢測方法包括先 將一血液施加於一檢測電極,再對該對檢測電極施加一電壓值,以取得一響應電流值,最後根據一預設判讀規則與該響應電流值,取得該血液之一血比容。According to an embodiment of the present invention, a blood specific volume detecting method includes Applying a blood to a detecting electrode, applying a voltage value to the pair of detecting electrodes to obtain a response current value, and finally obtaining a hematocrit of the blood according to a predetermined interpretation rule and the response current value.

根據本發明之另一實施例,血比容檢測系統包括一檢測單元與一檢測裝置。該檢測單元包括一對具有一接收部與一接觸部的檢測電極。該接收部用以接收一血液。該檢測裝置係連接該對檢測電極之該接觸部,並根據一預設判斷規則來對該接觸部施加一電壓值,以取得該血液之血比容。According to another embodiment of the invention, the hematocrit detection system includes a detection unit and a detection device. The detecting unit includes a pair of detecting electrodes having a receiving portion and a contact portion. The receiving portion is for receiving a blood. The detecting device is connected to the contact portion of the pair of detecting electrodes, and applies a voltage value to the contact portion according to a predetermined determining rule to obtain a blood specific volume of the blood.

因此,相較傳統應用電極試片的,本發明所揭露之血比容量測除了操作簡單,亦可提高精準度與可靠度。Therefore, compared with the conventional application of the electrode test piece, the blood specific capacity measurement disclosed in the present invention can improve the accuracy and reliability in addition to the simple operation.

請參考第1圖所示,第1圖為本發明血比容檢測系統之一實施例的示意圖。血比容檢測系統包括一檢測單元10與一檢測裝置20。該檢測單元10包括一對具有一接收部111與一接觸部112的檢測電極110,其中,該接收部111用以接收一血液。該檢測裝置20係連接該對檢測電極110之該接觸部112,並根據一預設判讀規則來對該接觸部112施加一電壓值,以取得該血液之血比容。Please refer to FIG. 1 , which is a schematic diagram of an embodiment of a hematocrit detection system of the present invention. The hematocrit detection system includes a detection unit 10 and a detection device 20. The detecting unit 10 includes a pair of detecting electrodes 110 having a receiving portion 111 and a contact portion 112 for receiving a blood. The detecting device 20 is connected to the contact portion 112 of the pair of detecting electrodes 110, and applies a voltage value to the contact portion 112 according to a predetermined interpretation rule to obtain the hematocrit of the blood.

該檢測裝置20包括一對連接埠210、一參考電壓源220與一控制器230。各該連接埠210之一第一端連接於該接觸部112,該參考電壓源220與其中一該 連接埠210之一第二端連接,用以提供檢測所需之該電壓值。該控制器230連接於另一該連接埠210之一第二端及該參考電壓源220,並透過接收該檢測單元10導電後之一響應電流值,來取得該血液之血比容。The detecting device 20 includes a pair of ports 210, a reference voltage source 220 and a controller 230. One of the first ends of each of the ports 210 is connected to the contact portion 112, and the reference voltage source 220 and one of the A second end of the port 210 is connected to provide the voltage value required for detection. The controller 230 is connected to the second terminal of the other connection port 210 and the reference voltage source 220, and receives the response current value of the detection unit 10 to obtain the blood specific volume of the blood.

如第2至4圖所示,第2圖為本發明血比容檢測系統中檢測單元之一實施例的分解示意圖,第3圖為本發明血比容檢測系統中檢測單元之另一實施例的分解示意圖,第4圖為本發明血比容檢測系統中檢測單元之一實施例的示意圖。於一實施例,如第3圖所示,該檢測單元10可為一試片設計,其包括一基板100、該對檢測電極110、一隔板130及一蓋板140。該對檢測電極110設置於該基板100上。該隔板130設置於該基板100上,其部分覆蓋該對檢測電極110,使該對檢測電極110之後端電極部分裸露,並包括於一開口131。該開口131開設於該隔板130之一前端,令該對檢測電極110對應於該開口131的前端電極部分裸露。該介面活性劑120覆蓋於該對檢測電極110上對應於該隔板130之開口131位置。2 to 4, FIG. 2 is an exploded perspective view showing an embodiment of a detecting unit in the blood specific volume detecting system of the present invention, and FIG. 3 is another embodiment of the detecting unit in the blood specific volume detecting system of the present invention. FIG. 4 is a schematic view showing an embodiment of a detecting unit in the blood specific volume detecting system of the present invention. In an embodiment, as shown in FIG. 3 , the detecting unit 10 can be a test piece design, and includes a substrate 100 , the pair of detecting electrodes 110 , a partition plate 130 , and a cover plate 140 . The pair of detecting electrodes 110 are disposed on the substrate 100. The spacer 130 is disposed on the substrate 100 and partially covers the pair of detecting electrodes 110 such that the end electrode portions of the pair of detecting electrodes 110 are exposed and included in an opening 131. The opening 131 is formed at a front end of the partition plate 130 such that the pair of detecting electrodes 110 are exposed corresponding to the front end electrode portion of the opening 131. The interface 120 covers the position of the opening 131 of the pair of detecting electrodes 110 corresponding to the spacer 130.

於此,該對檢測電極110的接收部111定義為裸露於該開口131位置的區域,該接觸部112則定義為該對檢測電極110未被該隔板130所覆蓋的後端電極。Here, the receiving portion 111 of the pair of detecting electrodes 110 is defined as a region exposed at the position of the opening 131, and the contact portion 112 is defined as a rear end electrode of the pair of detecting electrodes 110 not covered by the spacer 130.

於另一實施例,如第4圖所示,該檢測單元10另包括一介面活性劑120,該介面活性劑120係設至於該基板100上,並覆蓋該檢測電極110之接收部 111。In another embodiment, as shown in FIG. 4, the detecting unit 10 further includes an surfactant 120 disposed on the substrate 100 and covering the receiving portion of the detecting electrode 110. 111.

該蓋板140設置於該隔板130上,並包括一導口141與一導孔142。該導口141設置於該蓋板140之一前端,並與該隔板130之開口131重疊,該導孔142開設於該蓋板140對應於該隔板130之開口131位置,與該開口131形成一導通路徑。The cover plate 140 is disposed on the partition plate 130 and includes a guide port 141 and a guide hole 142. The guide port 141 is disposed at a front end of the cover plate 140 and overlaps with the opening 131 of the partition plate 130. The guide hole 142 is defined in the position of the cover plate 140 corresponding to the opening 131 of the partition plate 130, and the opening 131 A conduction path is formed.

根據一實施例,該基板100為一絕緣基板,其材質沒有特別的限制,其可為一聚對苯二甲酸乙二酯(PET)、聚氯乙烯(PVC)、玻璃纖板(FR-4)、聚碳酸酯(PC)、聚乙烯(PE)、聚丙烯(PP)、聚苯乙烯(PS)、聚酯(Polyester sulphone)、陶瓷板(CEM)、玻璃等非導電等材料。而隔板130與蓋板140的材質亦無特別的限制,其可與基板100使用一樣的材料。According to an embodiment, the substrate 100 is an insulating substrate, and the material thereof is not particularly limited, and may be polyethylene terephthalate (PET), polyvinyl chloride (PVC), or glass fiberboard (FR-4). ), non-conductive materials such as polycarbonate (PC), polyethylene (PE), polypropylene (PP), polystyrene (PS), polyester (Polyester sulphone), ceramic plate (CEM), and glass. The material of the spacer 130 and the cover 140 is not particularly limited, and the same material as that of the substrate 100 can be used.

根據一實施例,該對檢測電極110為一導電材料,但不限於金屬材質。該對檢測電極110可透過濺射法、蒸鍍法或網印方式,形成任一電極圖形(electrode pattern)於該基板100上。如第2圖所示,該對檢測電極110的電極圖形為兩個L型的電極相對設置,其兩短邊相互平行設置於該基板100之前端,其兩長邊相互平行設置於該基板100,且向後延伸至該基板100的後端。According to an embodiment, the pair of detecting electrodes 110 is a conductive material, but is not limited to a metal material. The pair of detecting electrodes 110 can form any electrode pattern on the substrate 100 by a sputtering method, an evaporation method, or a screen printing method. As shown in FIG. 2, the electrode patterns of the pair of detecting electrodes 110 are oppositely disposed on the two L-shaped electrodes, and the two short sides thereof are disposed in parallel with each other at the front end of the substrate 100, and the two long sides thereof are disposed in parallel with each other on the substrate 100. And extending rearward to the rear end of the substrate 100.

當一使用者透過一專用刺血針取血後,將血液滴在該導孔142,該導孔142與該隔板130之開口131所形成之該導通路徑會產生一毛細現象,讓血液透過開口131導入該檢測單元10,並與覆蓋有該介面活性 劑120的該對檢測電極110接觸。接著,再將該對檢測電極110之接觸部112與該檢測裝置20之該對連接埠210連接後,啟動該檢測裝置20。When a user takes blood through a special lancet, blood is dripped in the guide hole 142, and the conduction path formed by the guide hole 142 and the opening 131 of the spacer 130 generates a capillary phenomenon for allowing blood to pass through. The opening 131 is introduced into the detecting unit 10 and covered with the interface active The pair of detecting electrodes 110 of the agent 120 are in contact. Next, the contact portion 112 of the pair of detecting electrodes 110 is connected to the pair of ports 210 of the detecting device 20, and then the detecting device 20 is activated.

該控制器230驅動該參考電壓源220,以對該對檢測電極110之間施加一電壓值,該施加的電壓依附在該介面活性劑120的血液產生一電化學反應,進而形成一具有一響應電流的導通路徑,其響應電流值會因為血液的血比容而產生變化。該控制器230讀取該響應電流值,來判斷該受測血液的血比容。該控制器230於一單位時間內,可就不同的響應電流值來區分血液的血比容。The controller 230 drives the reference voltage source 220 to apply a voltage value between the pair of detecting electrodes 110, and the applied voltage is attached to the blood of the surfactant 120 to generate an electrochemical reaction, thereby forming a response. The conduction path of the current whose response current value changes due to the hematocrit of the blood. The controller 230 reads the response current value to determine the hematocrit of the blood to be measured. The controller 230 can distinguish the hematocrit of the blood for different response current values in one unit time.

請配合參考第5A至5C圖,第5A至5C圖分別為檢測裝置施加電壓於檢測單元時,於不同實施例中,響應電流與時間的關係變化示意圖。如第5A圖所示,該未添加介面活性劑120之40%血比容的響應電流值高於50%的血比容,50%高於60%,60%高於70%,70%高於90%,隨著血比容百分比越高,響應電流的變化相對趨緩。同理,如第5B圖所示的例子,該具介面活性劑120之41%的血比容的響應電流值高於60%的血比容。如第5C圖所示,該圖式分別表示38%、69%與75%之響應電流與時間的關係。Please refer to FIG. 5A to FIG. 5C. FIG. 5A to FIG. 5C are respectively schematic diagrams showing changes in response current versus time in different embodiments when a voltage is applied to the detecting unit by the detecting device. As shown in Fig. 5A, the 40% hematocrit response current value of the unadded surfactant 120 is higher than 50% hematocrit, 50% higher than 60%, 60% higher than 70%, 70% high. At 90%, the higher the hematocrit percentage, the slower the response current changes. Similarly, as shown in the example of FIG. 5B, the response specific current value of the hematocrit of 41% of the surfactant 120 is higher than the hematocrit of 60%. As shown in Fig. 5C, the graph shows the response current versus time for 38%, 69%, and 75%, respectively.

值得注意的是,由於該介面活性劑120同時具有親水與疏水特性,因此該介面活性劑120的塗佈可使血液中的物質均質、分散於血漿中,而使量測較穩定。It is worth noting that since the surfactant 120 has both hydrophilic and hydrophobic properties, the application of the surfactant 120 allows the substances in the blood to be homogenized and dispersed in the plasma to make the measurement stable.

於一實施例,該介面活性劑120係選自於由溴化 十六烷基三甲基銨(cetyltrimethylammonium bromide,CTAB)、辛基苯酚聚氧乙烯醇-X100(Triton X-100)、聚山梨醇酯(TWEEN)20、聚山梨醇酯(TWEEN)40、聚山梨醇酯(TWEEN)60、山梨醇酐單月桂酸酯(Span)20、羧甲基纖維素(Carboxymethyl cellulose,CMC)、膽酸鈉(sodium cholate)及硫酸月桂酸鈉(Sodium Dodecyl Sulphate,SDS)所組成之群組。In one embodiment, the surfactant 120 is selected from the group consisting of bromination Cetyltrimethylammonium bromide (CTAB), octylphenol polyoxyethylene alcohol-X100 (Triton X-100), polysorbate (TWEEN) 20, polysorbate (TWEEN) 40, poly Sorbitol ester (TWEEN) 60, sorbitan monosulphate (Span) 20, Carboxymethyl cellulose (CMC), sodium cholate and sodium decanoate (Sodium Dodecyl Sulphate, SDS) ) the group consisting of.

另外,於一實施例,該施加於該對檢測電極110的電壓值可為1至3伏特(Volts)之間,該單位時間可為0.01至1秒之間。為了讓該控制器230能夠有效且較精準對所接收之響應電流值來進行血比容的判讀,該控制器230需要預先(例如透過一電化學儀)進行設定,將不同百分比值的血比容的資料預存於該控制器230,以供每次檢測電流進行換算。In addition, in an embodiment, the voltage value applied to the pair of detecting electrodes 110 may be between 1 and 3 volts, and the unit time may be between 0.01 and 1 second. In order for the controller 230 to perform the hematocrit interpretation on the received response current value efficiently and accurately, the controller 230 needs to perform (for example, through an electrochemical device) to set the blood ratio of different percentage values. The data of the capacity is pre-stored in the controller 230 for conversion of each detected current.

請參考第6圖所示,第6圖為本發明血比容檢測方法之一實施例的流程圖。藉由上述血比容檢測系統,血比容檢測方法透過包括步驟有:S10將一血液施加於一對檢測電極;S12對該對檢測電極施加一電壓值,以取得一響應電流值;及S14根據一預設判讀規則與該響應電流值,取得該血液之一血比容。Please refer to FIG. 6, which is a flow chart of an embodiment of the blood specific volume detecting method of the present invention. According to the blood specific volume detecting system, the blood specific volume detecting method includes the steps of: applying a blood to a pair of detecting electrodes; S12 applying a voltage value to the pair of detecting electrodes to obtain a response current value; and S14 A blood specific volume of the blood is obtained according to a preset interpretation rule and the response current value.

其中,步驟S10所述之將血液施加於該對檢測電極,可視檢測電極的差異而有所不同,根據另一實施 例,該血液是施加於該對檢測電極塗覆有一介面活性劑。Wherein, the blood is applied to the pair of detecting electrodes as described in step S10, and the difference of the visible detecting electrodes is different, according to another implementation. For example, the blood is applied to the pair of detection electrodes coated with an surfactant.

該預設判讀規則包括多個血比容數據,該些數據是指在不同電壓值下,血比容與響應電流值變化量的關係,據此來判斷受測血液的血比容。The preset interpretation rule includes a plurality of hematocrit data, which are the relationship between the hematocrit and the amount of change in the response current value at different voltage values, and thereby determining the hematocrit of the blood to be measured.

因此,本發明相較傳統應用電極試片的血比容量測,使得血比容的量測除了操作簡單,亦可提高精準度與可靠度。Therefore, the blood specific capacity measurement of the present invention is higher than that of the conventional application electrode test piece, so that the measurement of the hematocrit can improve the accuracy and reliability in addition to the simple operation.

惟以上所述者,僅為本發明之較佳實施例,當不能用以限定本發明可實施之範圍,凡知悉本案領域具有通常技藝人士所明顯可作的變化與修飾,皆應視為不悖離本發明之實質內容。However, the above-mentioned preferred embodiments of the present invention are not intended to limit the scope of the invention, and any changes and modifications apparent to those skilled in the art should be considered as not The substance of the invention is removed.

10‧‧‧檢測單元10‧‧‧Detection unit

100‧‧‧基板100‧‧‧Substrate

110‧‧‧檢測電極110‧‧‧Detection electrode

111‧‧‧接收部111‧‧‧ Receiving Department

112‧‧‧接觸部112‧‧‧Contacts

120‧‧‧介面活性劑120‧‧‧Interfacial active agent

130‧‧‧隔板130‧‧‧Baffle

131‧‧‧開口131‧‧‧ openings

140‧‧‧蓋板140‧‧‧ cover

141‧‧‧導口141‧‧ ‧ guide

142‧‧‧導孔142‧‧‧ Guide hole

20‧‧‧檢測裝置20‧‧‧Detection device

210‧‧‧連接埠210‧‧‧Connector

220‧‧‧參考電壓源220‧‧‧reference voltage source

230‧‧‧控制器230‧‧‧ Controller

第1圖為本發明血比容檢測系統之一實施例的示意圖。Figure 1 is a schematic illustration of one embodiment of a hematocrit detection system of the present invention.

第2圖為本發明血比容檢測系統中檢測單元之一實施例的分解示意圖。Fig. 2 is an exploded perspective view showing an embodiment of a detecting unit in the blood specific volume detecting system of the present invention.

第3圖為本發明血比容檢測系統中檢測單元之一實施例的分解示意圖。Fig. 3 is an exploded perspective view showing an embodiment of a detecting unit in the blood specific volume detecting system of the present invention.

第4圖為本發明血比容檢測系統中檢測單元之一實施例的示意圖。Fig. 4 is a schematic view showing an embodiment of a detecting unit in the blood specific volume detecting system of the present invention.

第5A圖為檢測裝置施加電壓於檢測單元時,響應電流與時間的關係變化示意圖。Fig. 5A is a schematic diagram showing changes in response current versus time when a voltage is applied to the detecting unit by the detecting device.

第5B圖為檢測裝置施加電壓於檢測單元時,響應電流與時間的關係變化示意圖。FIG. 5B is a schematic diagram showing changes in response current versus time when a voltage is applied to the detecting unit by the detecting device.

第5C圖為檢測裝置施加電壓於檢測單元時,響應電流與時間的關係變化示意圖。Fig. 5C is a schematic diagram showing changes in response current versus time when a voltage is applied to the detecting unit by the detecting device.

第6圖為本發明血比容檢測方法之流程圖。Figure 6 is a flow chart of the blood specific volume detecting method of the present invention.

Claims (11)

一種血比容檢測方法,包括:將一血液施加於一對檢測電極;對該對檢測電極施加一電壓值,以取得一響應電流值;及根據一預設判讀規則與該響應電流值,取得該血液之一血比容;其中,該預設判讀規則是將該響應電流值與預先儲存之多個血比容數據進行比對,以判斷該響應電流值所對應之該血比容。 A blood specific volume detecting method includes: applying a blood to a pair of detecting electrodes; applying a voltage value to the pair of detecting electrodes to obtain a response current value; and obtaining according to a preset interpretation rule and the response current value One of the hematocrit of the blood; wherein the preset interpretation rule compares the response current value with a plurality of blood specific volume data stored in advance to determine the hematocrit corresponding to the response current value. 如申請專利範圍第1項所述之檢測方法,其中,該血液係施加於塗覆有一介面活性劑之該對檢測電極。 The method of detecting according to claim 1, wherein the blood system is applied to the pair of detecting electrodes coated with an surfactant. 如申請專利範圍第2項所述之檢測方法,其中,該介面活性劑係選自於由溴化十六烷基三甲基銨、辛基苯酚聚氧乙烯醇-X100、聚山梨醇酯20、聚山梨醇酯40、聚山梨醇酯60、山梨醇酐單月桂酸酯20、羧甲基纖維素、膽酸鈉及硫酸月桂酸鈉所組成之群組。 The detection method according to claim 2, wherein the surfactant is selected from the group consisting of cetyltrimethylammonium bromide, octylphenol polyoxyethylene alcohol-X100, polysorbate 20 A group consisting of polysorbate 40, polysorbate 60, sorbitan monolaurate 20, carboxymethylcellulose, sodium cholate and sodium laurate sulfate. 如申請專利範圍第1項所述之檢測方法,其中,該電壓值為1至3伏特(Volts)之間。 The detection method of claim 1, wherein the voltage value is between 1 and 3 volts (Volts). 一種血比容檢測系統,包括:一檢測單元,其包括一對具有一接收部與一接觸 部的檢測電極,其中,該接收部用以接收一血液;及一檢測裝置,連接該對檢測電極之該接觸部,並根據一預設判斷規則來對該接觸部施加一電壓值,以取得該血液之一血比容;其中,該檢測裝置預先儲存有多個血比容數據,該預設判斷規則是將該響應電流值與各該血比容數據進行比對,以判斷出對應於該響應電流值之該血比容。 A blood specific volume detecting system comprising: a detecting unit comprising a pair having a receiving portion and a contact a detecting electrode, wherein the receiving portion is configured to receive a blood; and a detecting device is connected to the contact portion of the pair of detecting electrodes, and applying a voltage value to the contact portion according to a predetermined determining rule to obtain a blood specific volume of the blood; wherein the detecting device pre-stores a plurality of hematocrit data, the preset determining rule is to compare the response current value with each of the hematocrit data to determine that the corresponding The hematocrit of the response current value. 如申請專利範圍第5項所述之檢測系統,其中,該檢測裝置更包括:一對連接埠,各該連接埠之一第一端連接於該接觸部;一參考電壓源,係與其中一該連接埠之一第二端連接,用以提供該電壓值;及一控制器,係連接於另一該連接埠之一第二端及該參考電壓源,並透過接收該響應電流值,來取得該血液之該血比容。 The detection system of claim 5, wherein the detecting device further comprises: a pair of connecting ports, one of the first ends of each of the connecting ports is connected to the contact portion; a reference voltage source is associated with one of a second end of the connection port is connected to provide the voltage value; and a controller is connected to the second end of the other connection port and the reference voltage source, and receives the response current value The hematocrit of the blood is obtained. 如申請專利範圍第6項所述之檢測系統,其中,該檢測單元更包括:一基板,係供該對檢測電極設置於其上;一隔板,係設置於該基板上,其部分覆蓋該對檢測電極,使該對檢測電極之後端電極部分裸露,並包括一開口開設於該隔板之前端,令該對檢測電極對應 於該開口的前端電極部分裸露;及一蓋板,係設置於該隔板上,並包括:一導口,設置於該蓋板之前端,並與該隔板的開口重疊;及一導孔,開設於該蓋板對應於該隔板之開口位置,與該開口形成一導通路徑。 The detection system of claim 6, wherein the detecting unit further comprises: a substrate for the pair of detecting electrodes disposed thereon; a spacer disposed on the substrate, partially covering the And the detection electrode is such that the end electrode portion of the pair of detection electrodes is exposed, and an opening is formed at a front end of the spacer, so that the pair of detection electrodes correspond to The front end electrode portion of the opening is exposed; and a cover plate is disposed on the partition plate, and includes: a guide port disposed at a front end of the cover plate and overlapping with the opening of the partition plate; and a guide hole Opening a cover corresponding to the opening position of the partition, forming a conduction path with the opening. 如申請專利範圍第7項所述之檢測系統,其中,該基板為一絕緣基板,該基板、該隔板與該蓋板之材質為一聚對苯二甲酸乙二酯(PET)、聚氯乙烯(PVC)、玻璃纖板(FR-4)、聚碳酸酯(PC)、聚乙烯(PE)、聚丙烯(PP)、聚苯乙烯(PS)、聚酯(Polyester sulphone)、陶瓷板(CEM)或玻璃。 The detection system of claim 7, wherein the substrate is an insulating substrate, and the substrate, the separator and the cover are made of polyethylene terephthalate (PET) and polychlorinated Ethylene (PVC), glass fiber reinforced plastic (FR-4), polycarbonate (PC), polyethylene (PE), polypropylene (PP), polystyrene (PS), polyester (Polyester sulphone), ceramic plate ( CEM) or glass. 如申請申請專利範圍第5項所述之檢測系統,其中,該檢測單元另包括一介面活性劑,該介面活性劑覆蓋於該對檢測電極之該接收部。 The detection system of claim 5, wherein the detecting unit further comprises an intervening agent covering the receiving portion of the pair of detecting electrodes. 如申請專利範圍第9項所述之檢測系統,其中,該介面活性劑係選自於由溴化十六烷基三甲基銨、辛基苯酚聚氧乙烯醇-X100、聚山梨醇酯20、聚山梨醇酯40、聚山梨醇酯60、山梨醇酐單月桂酸酯20、羧甲基纖維素、膽酸鈉及硫酸月桂酸鈉所組成之群組。 The detection system of claim 9, wherein the surfactant is selected from the group consisting of cetyltrimethylammonium bromide, octylphenol polyoxyethylene alcohol-X100, polysorbate 20 A group consisting of polysorbate 40, polysorbate 60, sorbitan monolaurate 20, carboxymethylcellulose, sodium cholate and sodium laurate sulfate. 如申請專利範圍第5項所述之檢測系統,其中,該電壓值為1至3伏特(Volts)之間。 The detection system of claim 5, wherein the voltage value is between 1 and 3 volts.
TW101144249A 2012-11-27 2012-11-27 Method and device for measuring hematocrit (hct) TWI482964B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW101144249A TWI482964B (en) 2012-11-27 2012-11-27 Method and device for measuring hematocrit (hct)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW101144249A TWI482964B (en) 2012-11-27 2012-11-27 Method and device for measuring hematocrit (hct)

Publications (2)

Publication Number Publication Date
TW201421022A TW201421022A (en) 2014-06-01
TWI482964B true TWI482964B (en) 2015-05-01

Family

ID=51393357

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101144249A TWI482964B (en) 2012-11-27 2012-11-27 Method and device for measuring hematocrit (hct)

Country Status (1)

Country Link
TW (1) TWI482964B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW466344B (en) * 2000-09-01 2001-12-01 Apex Biotechnology Corp Disposable electrode for whole blood hemoglobin (HGB) and hematocrit (HCT) measurement, and preparation and application thereof
TW200918886A (en) * 2007-10-19 2009-05-01 Gen Life Biotechnology Co Ltd Method of detecting hemoglobin or hematocrit by using electrochemistry and test stripe thereof
TW201122471A (en) * 2009-12-30 2011-07-01 Lifescan Inc Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity
JP2011141302A (en) * 2003-12-04 2011-07-21 Panasonic Corp HEMATOCRIT (Hct) MEASURING METHOD, SENSOR USED FOR SAME, AND MEASURING INSTRUMENT
JP2011257403A (en) * 2010-06-09 2011-12-22 Apex Biotechnology Corp Device and method for measuring prothrombin time and hematocrit by analyzing change in reactance in sample

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW466344B (en) * 2000-09-01 2001-12-01 Apex Biotechnology Corp Disposable electrode for whole blood hemoglobin (HGB) and hematocrit (HCT) measurement, and preparation and application thereof
JP2011141302A (en) * 2003-12-04 2011-07-21 Panasonic Corp HEMATOCRIT (Hct) MEASURING METHOD, SENSOR USED FOR SAME, AND MEASURING INSTRUMENT
TW200918886A (en) * 2007-10-19 2009-05-01 Gen Life Biotechnology Co Ltd Method of detecting hemoglobin or hematocrit by using electrochemistry and test stripe thereof
TW201122471A (en) * 2009-12-30 2011-07-01 Lifescan Inc Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity
JP2011257403A (en) * 2010-06-09 2011-12-22 Apex Biotechnology Corp Device and method for measuring prothrombin time and hematocrit by analyzing change in reactance in sample

Also Published As

Publication number Publication date
TW201421022A (en) 2014-06-01

Similar Documents

Publication Publication Date Title
US7144485B2 (en) Strips for analyzing samples
ES2546455T3 (en) Determination of partial filling in electrochemical strips
US9000770B2 (en) Electrochemical blood test strips and diagnosis systems using the same
TWI512287B (en) Electrochemical biosensing meter, system and measuring method for analyte measurement incorporating filled sample detection
TWI504889B (en) Hematocrit measurement system and measurement method using the same
US11740216B2 (en) Method and apparatus for measuring humidity using an electrochemical gas sensor
JP2017534064A5 (en)
JP2016502100A (en) Electrical connector for a substrate with conductive tracks
RU2689154C1 (en) Two-compartment analytical test strip
JP5809968B2 (en) Calibration solution
US20230103375A1 (en) Heavy metal detector
US20140246335A1 (en) Method of determining hematocrit value, quantative analysis method, and sensor chip
JP2014095675A (en) Electrochemical sensor, and sensor head
TWI482964B (en) Method and device for measuring hematocrit (hct)
US20150107994A1 (en) Biosensor
US20180348193A1 (en) Test Sensor Systems And Methods For Using The Same
US11307167B2 (en) Systems and methods for measuring electrolyte content in an electrochemical gas sensor
KR102519090B1 (en) Analyte Detection Meter and Associated Method of Use
TWI586333B (en) A blood volume detecting method and a detecting device using the same
US20140166503A1 (en) Method and device for measuring hematocrit
CN112540112B (en) Sensor calibration method, device, equipment and storage medium
US9039991B2 (en) Biosensors and bio-measurement systems using the same
JP6054159B2 (en) Automatic analyzer
TW201610427A (en) Examination method for detecting abnormal electrochemical test strip
TWI605250B (en) Examination method for detecting abnormal property of electrochemical test strip